Matthew, is a Chartered Patent Attorney and European Patent Attorney and heads up our Cambridge Biotechnology and Life Sciences Group

Partner

Matthew specialises in the preparation and prosecution of patent applications in the biotechnology, pharmaceuticals, biologics and healthcare fields. He regularly provides due diligence and freedom-to-operate advice to his clients in various technical areas and has particular expertise in diagnostic technologies; specifically biomarkers and personalised medicine, especially companion diagnostics, therapeutics including biologics, analyte detection technologies (including bacterial detection), pest control, fermentation processes, stem cell technologies and medical devices. He brings strategic and commercial advice to his clients and has extensive experience of supporting early stage companies seeking investment and development partners. He has also worked on a Patent Attorney’s Report for an Initial Public Offering of a pharmaceutical company specialising in plant derived medicines.

Matthew is highly experienced in developing drafting and prosecution strategies for key client portfolios worldwide. He regularly represents his clients in Oral Proceedings before the Opposition and Appeal Boards of the European Patent Office.

BIA CIPA EPI One Nucleus

Chartered UK Patent Attorney (awarded the Chartered Institute of Patent Attorneys Drafting prize) European Patent Attorney MA (Cantab) Natural Sciences, University of Cambridge MSci Biochemistry, University of Cambridge